AbbVie To Acquire Apogee And Its Diverse Pipeline Of Multiple Clinical-Stage Candidates In Development Across Inflammatory And Immunological Diseases For $135.11/Shr In Cash

뉴스 본문을 불러오고 있어요.

AbbVie To Acquire Apogee And Its Diverse Pipeline Of Multiple Clinical-Stage Candidates In Development Across Inflammatory And Immunological Diseases For $135.11/Shr In Cash | 웨이프 WAPE

AbbVie To Acquire Apogee And Its Diverse Pipeline Of Multiple Clinical-Stage Candidates In Development Across Inflammatory And Immunological Diseases For $135.11/Shr In Cash

기사 요약

관련 종목

댓글 —